Literature DB >> 2656931

Drug resistance in cancer: an overview of the clinical aspects.

P Periti1, E Mini.   

Abstract

The primary cause of failure of the pharmacological treatment of cancer is the occurrence of intrinsic or acquired resistance to drugs in tumor cells. Drug resistance occurs through a variety of mechanisms and usually results from mutation or amplification of genes. Biochemical and genetic mechanisms by which tumor cells may become resistant clinically to chemotherapeutic agents are reviewed. Strategies for preventing or circumventing drug resistance are also discussed.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2656931     DOI: 10.1080/1120009x.1989.11738856

Source DB:  PubMed          Journal:  J Chemother        ISSN: 1120-009X            Impact factor:   1.714


  5 in total

1.  miR-30a-5p enhances paclitaxel sensitivity in non-small cell lung cancer through targeting BCL-2 expression.

Authors:  Xiaojie Xu; Shuai Jin; Yongfu Ma; Zhongyi Fan; Zhifeng Yan; Wenchao Li; Qi Song; Wenye You; Zhaohui Lyu; Yeqiong Song; Pingan Shi; Ying Liu; Xiao Han; Ling Li; Ying Li; Yang Liu; Qinong Ye
Journal:  J Mol Med (Berl)       Date:  2017-05-09       Impact factor: 4.599

2.  MiR-125a promotes paclitaxel sensitivity in cervical cancer through altering STAT3 expression.

Authors:  Z Fan; H Cui; H Yu; Q Ji; L Kang; B Han; J Wang; Q Dong; Y Li; Z Yan; X Yan; X Zhang; Z Lin; Y Hu; S Jiao
Journal:  Oncogenesis       Date:  2016-02-15       Impact factor: 7.485

3.  Trastuzumab induces PUMA-dependent apoptosis and inhibits tumor growth in gastric cancer.

Authors:  Linghe Luo; Haiyan Liu; Qian Xi
Journal:  FEBS Open Bio       Date:  2018-11-19       Impact factor: 2.693

4.  MicroRNA-130b targets PTEN to induce resistance to cisplatin in lung cancer cells by activating Wnt/β-catenin pathway.

Authors:  Qiang Zhang; Bin Zhang; Leina Sun; Qingna Yan; Yu Zhang; Zhenfa Zhang; Yanjun Su; Changli Wang
Journal:  Cell Biochem Funct       Date:  2018-04-13       Impact factor: 3.685

5.  MicroRNA-34c-3p target inhibiting NOTCH1 suppresses chemosensitivity and metastasis of non-small cell lung cancer.

Authors:  Lin-Zhu Yang; Chang-Cheng Lei; Yun-Ping Zhao; Hong-Wen Sun; Qing-He Yu; En-Ji Yang; Xi Zhan
Journal:  J Int Med Res       Date:  2020-03       Impact factor: 1.671

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.